Indirect costs of adult pneumococcal disease and the productivity-based rate of return to the 13-valent pneumococcal conjugate vaccine for adults in Turkey
Sevilla, J. P., Stawasz, Andrew, Burnes, Daria, Agarwal, Anubhav, Hacibedel, Basak, Helvacioglu, Kerem, Sato, Reiko, Bloom, David E.Language:
english
Journal:
Human Vaccines & Immunotherapeutics
DOI:
10.1080/21645515.2019.1708668
Date:
January, 2020
File:
PDF, 2.22 MB
english, 2020